Skip to main content
Premium Trial:

Request an Annual Quote

Stephen Zaniboni, John Sharp, Christopher Yoo, Ed Southern, Alec Jeffreys, Jon Kleinberg, Pehr Harbury, Greiner Bio-One, Affymetrix, Beckman Coulter, Full Moon, Innopsys, Tecan



Stephen Zaniboni, CFO of Sequenom, will step down from his post during the fourth quarter, the company said in an SEC filing last week. Sequenom plans to consolidate the CFO position with that of the vice president of finance, which is currently held by John Sharp.

Christopher Yoo has joined the InnovationXchange Network, an Australia-based non-profit business development organization, to lead business operations in the Americas and internationally, GenomeWeb News has learned. Yoo was formerly director of marketing, commercial operations, at Applied Biosystems and previously worked at IBM as global strategy executive for the company's Information Based Medicine business unit.

Ed Southern and Alec Jeffreys have won the 2005 Albert Lasker Award for Clinical Medical Research, the Albert and Mary Lasker Foundation said on Sunday. Southern, of the University of Oxford, receives the award for inventing the Southern blot technique. Jeffreys, of the University of Leicester, UK, is honored for inventing genetic fingerprinting.

Jon Kleinberg and Pehr Harbury are among the 25 new MacArthur Fellows for 2005 named this week by the John D. and Catherine T. MacArthur Foundation. Each will receive $500,000 over the next five years with "no strings attached."

Kleinberg, 33, is a professor of computer science at Cornell University. Among other topics, his research has focused on comparative genomics and protein structures, although he is best known for his contributions to network theory. He holds a PhD and an SM from the Massachusetts Institute of Technology and an AB from Cornell University.

Pehr Harbury, 40, is an associate professor of biochemistry at Stanford University. He has been exploring the structure, activity, and synthesis of proteins with the aim of developing more potent and specific drugs. Harbury holds a PhD and a BA from Harvard University.


New Releases

Greiner Bio-One last week introduced its HTA Plate, a polymer based platform for high throughput microarrays.

Current plate chemistries from Greiner include 3D Matrices for ionic (amino) and covalent (aldehyde) surfaces, which can be used for protein, oligonucleotide, and DNA binding.

Specialized buffer systems, co-developed with Scienion, are also being offered as companion products for processing and hybridization, Greiner said.

Affymetrix has awarded Beckman Coulter's ArrayPlex system for automated target RNA preparation with the label Premier Application Status, which will enable Beckman Coulter to market and support ArrayPlex to the Affymetrix customer base, the companies announced last week.

The ArrayPlex application includes automated instrumentation, software and protocols on the Biomek FX Liquid Handling Workstation.

Full Moon BioSystems last week launched its Microarray QC Kit, which the company intends for checking the quality of home-made arrays and/or commercial arrays prior to hybridization, to quantify printed DNA, or to verify the quality of targets and probes.

Specifically, the QC kit allows users to assess array quality: spot morphology, consistency and attachment and verify target and probe quality to enhance hybridization effectiveness, Full Moon said.

Innopsys last week launched its InnoScan700 microarray scanner for reading the results of fluorescence-based microarray experiments.

Tecan recently launched its HS 400 and HS 4800 hybridization stations for performing automated microarray processing on slides.

Tecan said the HS 400 is ideal for small-to-medium laboratories, while the HS 4800 offers higher capacity for more demanding throughput requirements. Both can be used for in situ hybridization with DNA and protein microarrays, according to Tecan.

Filed under

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.